Payment power
How to become investigator sites’ payments sponsor of choice
PharmaTimes Magazine
PharmaTimes is the UK's leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.
PharmaTimes print and digital versions have a total circulation of 23,184, reaching right across the industry into every company and every function. What's more, our circulation includes 8,000 NHS healthcare professionals: chief pharmacists, medicines management and primary care commissioners.
Click to subscribe to PharmaTimes in paper or print, or to sign up for our industry-leading daily and weekly news elerts.
You can read the latest issue as well as our extensive archive below or get in touch with the editorial or sales team.
Magazine highlights
View more from the latest edition
Embracing programmatic advertising
How targeted digital advertising could help pharma marketers avoid some of the industry’s most common pitfalls
Feeling the squeeze?
Paul Midgley, director of NHS Insight at Wilmington Healthcare, explains how Capped Expenditure Processes (CEP) will impact both NHS services and pharma sales
A reality check for the genomic revolution
Inside the technological, legislative and financial checks on the rise of genome-based medicine
Going public
Jaak Peeters, head of Johnson & Johnson Global Public Health, on pharma’s role in supporting global health, fighting epidemics and making medicines accessible
Clearing the way of secondary patents
The unusual circumstances of Fujifilm and AbbVie’s Humira patent case and its potential impacts on the market
Hollow Victory?
The NHS scores better than many other countries in terms of access to health – until you take outcomes into account
Intelligent design
PharmaTimes speaks to AI expert Jackie Hunter about the future of these technologies in R&D
